Most Women With Early Stage Breast Cancer Can Forgo Chemotherapy When Guided by a Diagnostic Test
A federally funded phase III clinical trial shows that most women with hormone receptor-positive, HER2-negative,…
A federally funded phase III clinical trial shows that most women with hormone receptor-positive, HER2-negative,…